FDA Reports Class I Recall on Some Terumo Balloon Systems

May 30, 2019, 6:35 PM UTC

Terumo Medical recalls Solopath balloon expandable transfemoral system and re-collapsible balloon access system due to dislodgement of the fairing tip from the sheath, according to FDA statement.

  • FDA has identified this as a Class I recall, the most serious type, which indicates use of recalled devices may cause serious injuries or death
  • Use of affected devices could cause injuries including vessel tears, hemorrhage, and vessel perforation
  • Teromo has received total of 14 reports of related incidents in which the device has malfunctioned in this manner, including two injuries
  • No deaths have been reported

©2019 Bloomberg L.P. All rights reserved. ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.